OTCPK:MAGA.A

Stock Analysis Report

Executive Summary

Magna-Lab Inc. does not have significant operations.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • Magna-Lab has significant price volatility in the past 3 months.
  • Magna-Lab is not covered by any analysts.

Share Price & News

How has Magna-Lab's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

0%

OTCPK:MAGA.A

1.5%

US Medical Equipment

0.8%

US Market


1 Year Return

540.0%

OTCPK:MAGA.A

9.7%

US Medical Equipment

1.9%

US Market

MAGA.A outperformed the Medical Equipment industry which returned 9.7% over the past year.

MAGA.A outperformed the Market in United States of America which returned 1.9% over the past year.


Share holder returns

MAGA.AIndustryMarket
7 Day0%1.5%0.8%
30 Day6.7%0.7%3.4%
90 Day-23.8%2.4%2.1%
1 Year540.0%540.0%10.6%9.7%4.2%1.9%
3 Yearn/a70.2%65.0%46.7%37.2%
5 Year33.3%33.3%136.0%109.1%62.3%44.5%

Price Volatility Vs. Market

How volatile is Magna-Lab's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Magna-Lab undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether Magna-Lab is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Magna-Lab has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of MAGA.A’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Magna-Lab regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Magna-Lab expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.1%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Magna-Lab has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of MAGA.A’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Magna-Lab's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Magna-Lab performed over the past 5 years?

-7.7%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Magna-Lab does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare Magna-Lab's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Magna-Lab's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Magna-Lab has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if Magna-Lab has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Magna-Lab improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is Magna-Lab's financial position?


Financial Position Analysis

Magna-Lab's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

Magna-Lab has no long term commitments.


Debt to Equity History and Analysis

Magna-Lab has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if Magna-Lab's debt level has increased considering it has negative shareholder equity.


Balance Sheet

Low level of unsold assets.

Magna-Lab has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Magna-Lab has less than a year of cash runway based on current free cash flow.

Magna-Lab has less than a year of cash runway if free cash flow continues to reduce at historical rates of -17.9% each year.


Next Steps

Dividend

What is Magna-Lab's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Magna-Lab's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Magna-Lab's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Magna-Lab has not reported any payouts.

Unable to verify if Magna-Lab's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Magna-Lab has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Magna-Lab's salary, the management and board of directors tenure and is there insider trading?

19.7yrs

Average board tenure


CEO

Lawrence Minkoff (69yo)

15.3yrs

Tenure

0

Dr. Lawrence A. Minkoff, Ph.D. is the Founder of Magna-Lab Inc. and has been its Chairman since May 1, 2004 and serves as its Chief Executive Officer. Dr. Minkoff has been President and Chief Scientific Of ...


Board Age and Tenure

19.7yrs

Average Tenure

69yo

Average Age

The average tenure for the Magna-Lab board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month open market individual insider trading information.


Ownership Breakdown


Management Team

  • Lawrence Minkoff (69yo)

    Founder

    • Tenure: 15.3yrs
  • Jerome Feldman (74yo)

    VP & Director

    • Tenure: 19.7yrs
    • Compensation: US$256.50k
  • Kenneth Riscica (65yo)

    CFO, Treasurer & Secretary

    • Tenure: 0yrs
    • Compensation: US$139.08k

Board Members

  • Lawrence Minkoff (69yo)

    Founder

    • Tenure: 15.3yrs
  • Joel Kanter (62yo)

    Director

    • Tenure: 21.5yrs
  • Jerome Feldman (74yo)

    VP & Director

    • Tenure: 19.7yrs
    • Compensation: US$256.50k

Company Information

Magna-Lab Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Magna-Lab Inc.
  • Ticker: MAGA.A
  • Exchange: OTCPK
  • Founded: 1991
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$188.692k
  • Shares outstanding: 1.18m
  • Website: https://null

Location

  • Magna-Lab Inc.
  • 1662 Old Country Road
  • Suite 355
  • Plainview
  • New York
  • 11803
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MAGA.AOTCPK (Pink Sheets LLC)YesClass A Common StockUSUSDMar 1993

Biography

Magna-Lab Inc. does not have significant operations. It intends to identify and merge with an operating company. Previously, the company was engaged in the research, development, and commercialization of d ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 23:51
End of Day Share Price2019/08/26 00:00
Earnings2019/05/31
Annual Earnings2019/02/28


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.